Patient P-02410
Synthetic patientMETA-24 · Day 170 · 35–44 · M · baseline S01Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Stable
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
58%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S01
- Day 72 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 75 GI-04 recommended — GI Support Protocol GI-04
- Day 76 Patient accepted — Started GI-04 in the companion
- Day 84 GI symptom burden −32% vs expected — GI Support Protocol GI-04
- Day 90 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 72.
Primary contributors, last 14 days
- Inflammatory activity+8
- GI instability+4
- Treatment adherence+3
- Toxicity+3
- Nutritional resilience-2
What helped?
- GI Support Protocol GI-04Day 75Result: symptom burden −32%
LIFE OS recommendation
Monitoring Escalation ME-01
73%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 3 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable29 min
improving · +9.4 vs previous 14 d
Sleep duration
Wearable6 h
stable · +0.2 vs previous 14 d
Energy level
Daily log3.7/10
improving · +0.6 vs previous 14 d
Steps
Wearable3,445
improving · +930 vs previous 14 d
GI burden
Companion53.1/100
improving · -4.2 vs previous 14 d
Adherence
Companion49.7 %
worsening · -2.9 vs previous 14 d
Sleep quality
Wearable38.1/100
improving · +3.4 vs previous 14 d
Glucose, CGM daily mean
CGM139 mg/dL
stable · -1.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 39 from the failing basin, 51 from restoration.
Would help
- ME-01 Monitoring Escalation100% improved among 42 similar · onset 3 d · confidence 61%
- NP-02 Dietary Support Protocol59% improved among 32 similar · onset 10 d · confidence 61%
- CR-01 Clinician Review100% improved among 6 similar · onset 5 d · confidence 61%
- More proteinGI -5.5 next day on high-intake days · n 22
- More alcoholGI -3.6 next day on high-intake days · n 14
Would not help
- Keep fat lowGI +5.2 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.5supporter · 95%
- Dietary fat load+5.2detractor · 95%
- Alcohol-3.6supporter · 79%
- Insoluble fibre+1.6no signal · 36%
- Ultra-processed food-1.4no signal · 32%
- Caffeine-0.5no signal · 15%
- Histamine load-0.4no signal · 15%
- Simple carbohydrates+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓55
- MicrobiomeButyrate capacity 27/100
- Daily logFibre intake low in recent food logs
- Inflammatory signalling ↑45
- MicrobiomeBacteroides fragilis expansion
- BloodInflammatory load index 50
- Autonomic recovery ↓40
- Wearable3,445 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓30
- Daily logGI symptom score 53 and rising
- WearableSleep 6.0 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.1 · butyrate capacity 27/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 56 ms
- Sleep
- 6.1 h
- Steps
- 3,686
- Resting HR
- 67 bpm
Daily log: GI score 53, nutritional resilience 44, adherence 50.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02048 | 23% | S02 | — | — | 77 |
| P-02115 | 23% | S14 | GI-04 | improved | 75 |
| P-02388 | 22% | S11 | — | — | 75 |
| P-02575 | 23% | S14 | ME-01 | improved | 73 |
| P-02403 | 22% | S03 | — | — | 71 |
| P-02335 | 23% | S04 | — | — | 70 |
| P-02550 | 23% | S01 | — | — | 70 |
| P-02192 | 22% | S05 | — | — | 69 |
| P-02659 | 28% | S09 | — | — | 69 |
| P-02214 | 22% | S08 | SC-12 | no change | 69 |
| P-02356 | 23% | S08 | — | — | 69 |
| P-02293 | 22% | S15 | HY-01 | no change | 68 |